Ovid Therapeutics Secures $75,000,000 Series B Financing

  • Feed Type
  • Date
    8/12/2015
  • Company Name
    Ovid Therapeutics
  • Mailing Address
    205 East 42nd Street New York, NY 10017 USA
  • Company Description
    Ovid Therapeutics Inc. is named for the Roman poet, Publius Ovidius Naso (Ovid), known for his epic work, Metamorphoses or Books of Transformations. Ovid is passionately committed to transforming the lives of patients with rare and orphan diseases of the brain—patients who currently have few if any treatment options or prospects for cure or improvement.
  • Website
    http://www.ovidrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $75,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Ovid plans to use the funds to advance several other internal compounds into clinical testing, and to further expand its pipeline.
  • M&A Terms
  • Venture Investor
    Fidelity Management & Research Company
  • Venture Investor
    Undisclosed